(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

THE PHALLOFILL CLINIC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

THE PHALLOFILL CLINIC

ST13

US500000090644997

Class

44

Filing

90644997

Registration

6982898

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

07/01/2023

Trademark type

Combined

Nice classes

44

Filing date

04/14/2021

Registration date

02/21/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/21/2023

Last transaction

07/01/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

03/17/2021

First use in commerce

03/18/2021

Drawing code

3

Owner type

16

Owner location

DALLAS, TX

Examiner

LEIPZIG, MARC J

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording THE PHALLOFILL CLINIC where the wording THE appears above the term PHALLOFILL, which is in larger font and the word CLINIC is underneath the letters FILL; and below the wording and aligned under the letter "O" are three interlocking vertical rings that get progressively larger in size and darker in shading.

Holders and representatives

Holders

THE PHALLOFILL CLINICS, LLC
Lush Investments, Inc.

Representatives

Sheryl De Luca NIXON & VANDERHYE P.C.

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Cosmetic and plastic surgery; performing surgical and medical treatmentcounselingprocedures for the purpose of penis enhancement and penis enlargementpenis treatment to improve sexual performance and treatment of erectile dysfunction; providing medical and surgical information to patients and physicians about penis enhancement and penis enlargementpenis treatment to improve sexual performance and treatment of erectile dysfunction

Publications

History of USPTO decisions and trademark events.

41 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/20/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/20/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/20/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/20/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/20/2023

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/31/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/21/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

02/21/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/06/2022

PUBO

PUBLISHED FOR OPPOSITION

12/06/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/16/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/31/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/31/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/31/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/31/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/29/2022

GNRT

NON-FINAL ACTION E-MAILED

09/29/2022

CNRT

NON-FINAL ACTION WRITTEN

09/29/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/06/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/05/2022

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

09/05/2022

RDX3

NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED

05/16/2022

RDX1

ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED

05/16/2022

RRDX

ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED

05/16/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/20/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/18/2022

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

04/18/2022

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

03/07/2022

GNFR

FINAL REFUSAL E-MAILED

03/07/2022

CNFR

FINAL REFUSAL WRITTEN

03/07/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/01/2022

ALIE

ASSIGNED TO LIE

02/01/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/31/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/31/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/08/2021

GNRT

NON-FINAL ACTION E-MAILED

12/08/2021

CNRT

NON-FINAL ACTION WRITTEN

12/08/2021

DOCK

ASSIGNED TO EXAMINER

12/06/2021

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

07/22/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/21/2021

NWAP

NEW APPLICATION ENTERED

04/17/2021

Continuous trademark protection

Get notified about every new filing that threatens THE PHALLOFILL CLINIC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.